Experience with Empirical Treatment of Severe Acute Respiratory Syndrome Due to Coronavirus, Genotype IV

Experience with Empirical Treatment of Severe Acute Respiratory Syndrome Due to Coronavirus, Genotype IV

Foreign experience with empirical management of severe acute respiratory syndrome (SARS) due to coronavirus, genotype IV is described. It is indicated that the data on the efficacy of ribavirin with respect to SARS in the patients are contradictory. The efficacy of two chemotherapeutics, i. e. lopin...

Full description

Saved in:
Bibliographic Details
Main Authors: V. N. Shchukina, S. Ya. Loginova, S. V. Borisevich, V. P. Bondarev
Format: Article
Language:Russian
Published: LLC "Publishing House OKI" 2020-05-01
Series:Антибиотики и Химиотерапия
Subjects:
severe acute respiratory syndrome
antiviral activity
coronavirus infection
chemotherapy
ribavirin
lopinavir
ritonavir
Online Access:https://www.antibiotics-chemotherapy.ru/jour/article/view/391
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items